duloxetine hydrochloride has been researched along with Cancer of Gastrointestinal Tract in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahles, T; Bressler, LR; Cirrincione, C; Fadul, CE; Fleishman, S; Le-Lindqwister, N; Loprinzi, C; Pang, H; Paskett, ED; Shapiro, CL; Smith, EM; Ye, C | 1 |
1 other study(ies) available for duloxetine hydrochloride and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Topics: Adult; Aged; Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Female; Gastrointestinal Neoplasms; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |